Propionibacterium endocarditis: A case series from the International Collaboration on Endocarditis Merged Database and Prospective Cohort Study
Tahaniyat Lalani(Henry M. Jackson Foundation), The International Collaboration On(Clinical Research Institute), Anna K. Person(Duke Medical Center), Hasan Shahbaz(Dallas VA Medical Center), Gail Peterson(Southwestern Medical Center), Lars Olaison, S. Susan Hedayati(Veterans Health Administration), Elías Abrutyn(Drexel University), Ulrika Snygg‐Martin, Christopher H. Cabell(Pfizer (United States)), Didier Raoult(Aix-Marseille Université), Susannah Eykyn(St Thomas' Hospital), Fredy Suter(Azienda Ospedaliero-Universitaria delle Marche), D.W.M. Verhagen(Amsterdam University of the Arts), Khaula Baloch(Clinical Research Institute), José M. Miró(Universitat Autònoma de Barcelona), Bruno Hoen(Centre Hospitalier Universitaire de Besançon), Laura J. Moore, J. T. van der Meer(Amsterdam University of the Arts), Dennis Spelman(The Alfred Hospital), David Murdoch(The University of Queensland), Jacob Strahilevitz(Hebrew University of Jerusalem)
Cited by 51
Related Papers
Gut microbiome influences efficacy of PD-1–based immunotherapy against epithelial tumors
|Science|2017|5.4k
Prevention of Infective Endocarditis
|Circulation|2007|2.8k
Clinical Presentation, Etiology, and Outcome of Infective Endocarditis in the 21st Century
|Archives of Internal Medicine|2009|2.3k
The abundance and variety of carbohydrate-active enzymes in the human gut microbiota
|Nature Reviews Microbiology|2013|1.7k
Daptomycin versus Standard Therapy for Bacteremia and Endocarditis Caused by <i>Staphylococcus aureus</i>
|New England Journal of Medicine|2006|1.5k